- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 532.6382 ↓ -0.27%
[as on 15 May, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH and its peers as on 15 May, 2026
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | -12.62% | 2.71% | -8.64% | 0.65% | 68.71% | 20.05% | -4.78% | 40.03% | 43.86% | -2.89% |
Discrete returns (monthly)
| Month | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 |
|---|
| Returns | 2.35% | -1.12% | -1.93% | 2.61% | 0.63% | -2.82% | -3.5% | 6.36% | -3.54% | 5.89% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | 17.37% | 7.1% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 98.16% |
0.07% (Arbitrage: 0.00%) |
0.00% |
0.00% |
1.77% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 12.11% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.59% |
| Acutaas Chemicals Ltd. | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 5.67% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.48% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 4.97% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.10% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 3.96% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.74% |
| Aether Industries Ltd. | AETHER (INE0BWX01014) | Chemicals & Petrochemicals | 3.56% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 3.33% |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 3.17% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.16% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 2.93% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 2.93% |
| Jupiter Life Line Hospitals Ltd. | JLHL (INE682M01012) | Healthcare Services | 2.84% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.61% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.57% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 2.50% |
| Krishna Institute of Medical Sciences Ltd. | KIMS (INE967H01025) | Healthcare Services | 2.45% |
| Sai Life Sciences Ltd. | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.24% |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 2.07% |
| Sudeep Pharma Ltd. | INE0QPI01025 | Pharmaceuticals & Biotechnology | 1.98% |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 1.91% |
| Polymedicure Ltd. | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 1.88% |
| Concord Biotech Ltd. | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 1.80% |
| Nephrocare Health Service Pvt. Ltd. | INE428V01029 | Healthcare Services | 1.00% |
| Cohance Lifesciences Ltd. | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 0.89% |
| Sanofi Consumer Healthcare India Ltd. | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 0.63% |
| Gufic Biosciences Ltd. | GUFICBIO (INE742B01025) | Pharmaceuticals & Biotechnology | 0.54% |
| Vijaya Diagnostic Centre Ltd. | VIJAYA (INE043W01024) | Healthcare Services | 0.53% |
| Medplus Health Services Ltd. | MEDPLUS (INE804L01022) | Retailing | 0.41% |
| Rainbow Children's Medicare Ltd. | RAINBOW (INE961O01016) | Healthcare Services | 0.35% |
| Corona Remedies Ltd. | INE02ZQ01018 | Pharmaceuticals & Biotechnology | 0.29% |
| Lonza Group | US54338V1017 | Pharmaceuticals & Biotechnology | 2.97% |
Debt
| Name | Rating | Weight % |
|---|
| 364 DAY T-BILL 19.11.26 | Sovereign | 0.07% |
Portfolio data is as on date 31 March, 2026
NAV history
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|
| 15 May, 2026 | 532.6382 | -0.27% |
| 14 May, 2026 | 534.0602 | 1.17% |
| 13 May, 2026 | 527.9082 | 0.37% |
| 12 May, 2026 | 525.9604 | -1.36% |
| 11 May, 2026 | 533.1953 | 0.97% |
| 8 May, 2026 | 528.0947 | 0.36% |
| 7 May, 2026 | 526.2109 | 0.29% |
| 6 May, 2026 | 524.6682 | 1.61% |
| 5 May, 2026 | 516.3356 | 0.08% |
| 4 May, 2026 | 515.9181 | 1.76% |
| 30 April, 2026 | 507.0144 | 0.23% |
| 29 April, 2026 | 505.8588 | 0.31% |
| 28 April, 2026 | 504.2791 | -0.27% |
| 27 April, 2026 | 505.6352 | 2.76% |
| 24 April, 2026 | 492.0527 | -1.51% |
| 23 April, 2026 | 499.6100 | 0.27% |
| 22 April, 2026 | 498.2731 | 0.32% |
| 21 April, 2026 | 496.7055 | 0.07% |
| 20 April, 2026 | 496.3688 | -0.09% |
| 17 April, 2026 | 496.8207 | 0.65% |
| 16 April, 2026 | 493.6271 | 0.06% |
| 15 April, 2026 | 493.3184 | 1.28% |
| 13 April, 2026 | 487.0913 | -0.26% |
| 10 April, 2026 | 488.3734 | 0.88% |
| 9 April, 2026 | 484.1090 | 0.62% |
| 8 April, 2026 | 481.1472 | 1.47% |
| 7 April, 2026 | 474.1940 | 0.17% |
| 6 April, 2026 | 473.3857 | 0.34% |
| 2 April, 2026 | 471.7953 | -1.46% |
| 1 April, 2026 | 478.8006 | |
FAQ (Frequently asked questions)
What is latest/current NAV/price of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The latest NAV of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH is 532.6382 as on 15 May, 2026.
What are YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 9.97% as on 15 May, 2026.
What are 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 11.43% as on 15 May, 2026.
What are 3 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 3 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 27.41% as on 15 May, 2026.
What are 5 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 5 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 17.15% as on 15 May, 2026.
What are 10 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 10 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 17.15% as on 15 May, 2026.
